What is the maximum dose of propranolol (beta blocker) for hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Propranolol for Hypertension

The maximum dose of propranolol for hypertension is 640 mg daily, though most patients achieve adequate blood pressure control at 120-160 mg daily, and the dose-response curve typically flattens after 160 mg daily. 1, 2

Standard Dosing Algorithm

Initial Dosing

  • Start with 80 mg once daily (extended-release) or 80-160 mg daily in 2 divided doses (immediate-release) 1, 3, 2
  • Administer with food to reduce hypoglycemia risk 3

Titration Strategy

  • Increase to 120 mg once daily if blood pressure remains uncontrolled after initial dosing 1, 2
  • Usual maintenance dose: 120-160 mg once daily for extended-release or divided doses for immediate-release 1, 3
  • Time to full hypertensive response is variable, ranging from a few days to several weeks 2

Maximum Dosing

  • Absolute maximum: 640 mg daily 1, 2
  • However, most antihypertensive effect occurs at 80-160 mg daily, with minimal additional benefit at higher doses 4, 5
  • Research demonstrates that the dose-response curve flattens after 160 mg daily, meaning higher doses provide little additional blood pressure reduction 4, 6, 5

Critical Pre-Treatment Assessment

Absolute Contraindications to Screen For

  • Second or third-degree heart block 3, 7, 8
  • Decompensated heart failure 3, 7, 8
  • Asthma or obstructive airway disease 3, 7, 8
  • Cardiogenic shock 7, 8
  • Sinus node dysfunction without pacemaker 7, 8
  • Severe bradycardia or hypotension 8

Baseline Assessment Required

  • Heart rate and blood pressure measurement 3, 8
  • Cardiovascular examination with auscultation 3
  • Screen for history of bronchospasm, diabetes, and concurrent medications affecting cardiac conduction 3, 8
  • ECG and echocardiogram only needed if cardiac abnormalities suspected 8

Monitoring During Titration

  • Monitor for hypotension and bradycardia, especially during dose escalation 3, 8
  • Check heart rate and blood pressure with each significant dose increase 7
  • Watch for signs of excessive beta-blockade: dizziness, extreme fatigue, syncope 8
  • No routine vital sign monitoring required between appointments if patient is stable and asymptomatic 3

Common Pitfalls and Safety Considerations

Discontinuation Protocol

  • Never abruptly discontinue propranolol after chronic use 1, 3, 7, 8
  • Taper gradually over several weeks to prevent rebound hypertension, tachycardia, or angina 3, 7, 8

Drug Interactions

  • Avoid routine combination with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to increased risk of bradycardia and heart block 3

Special Populations

  • Elderly patients require lower starting doses (40 mg twice daily or 80 mg extended-release) and more gradual titration due to increased sensitivity to beta-blockers 8
  • Propranolol may mask hypoglycemia symptoms in diabetic patients 3

Temporary Discontinuation Indications

  • Hold doses during diminished oral intake or vomiting 3, 8
  • Temporarily discontinue if wheezing requiring treatment develops 3

Clinical Context for Dose Selection

Propranolol is not recommended as a first-line agent for hypertension unless the patient has ischemic heart disease or heart failure 1. When used, it is typically combined with a thiazide diuretic, with over 80% of patients achieving control on doses up to 480 mg/day in combination therapy 9. However, research consistently shows that 80-160 mg daily induces most of the antihypertensive effect, with complete cardiac chronotropic beta-blockade not necessary for full hypotensive effect 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medication Transition from Flupentixol/Melitracen to Propranolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antihypertensive effect of propranolol at rest and during exercise.

British journal of clinical pharmacology, 1983

Research

Propranolol in hypertension: a dose-response study.

British medical journal, 1976

Guideline

Propranolol Dosing and Precautions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Propranolol Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.